Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier

Inclusion Criteria: * Patient with refractory heavy menstrual bleeding scheduled for endometrial ablation with Novasure system * Women 30 years old or older; * Subjects who are willing to provide a written informed consent as approved by the applicable Ethics Committee / IRB prior to participating in this clinical investigation. * Subjects who can comply with the study follow-up and other study requirements. Exclusion Criteria: * Cavity length \<4 or \>8 * Perforation during ablation procedure * Previous adhesiolysis procedure or diagnosis of Asherman's disease. * Abnormal uterine cavity at the time of ablation according to ESHRE classification I to V such as unicornis, bicornis, septate, duplex * History of cervical or endometrial cancer * Active pelvic infection or history of pelvic peritonitis * Known contraindication or hypersensitivity to Womed Leaf component * Current participation in another clinical investigation that has not yet received the primary endpoint * Any other condition that makes participation in the study contrary to the patient's best interests.